Desloratadine/pseudoephedrine explained
| Type: | combo |
| Component1: | Desloratadine |
| Class1: | Antihistamine |
| Component2: | Pseudoephedrine |
| Class2: | Decongestant |
| Tradename: | Clarinex-D, Aerinaze |
| Dailymedid: | Clarinex-D |
| Routes Of Administration: | By mouth |
| Atc Prefix: | R01 |
| Atc Suffix: | BA52 |
| Legal Us: | Rx-only |
| Legal Eu: | Rx-only |
| Legal Status: | Rx-only |
| Cas Number: | 2447632-94-0 |
| Kegg: | D10850 |
Desloratadine/pseudoephedrine, sold under the brand name Clarinex-D among others, is a medication used for the treatment of seasonal allergic rhinitis.
Desloratadine/pseudoephedrine was approved for use in the United States in 2005[1] [2] and in the European Union in July 2007.[3]
Medical uses
Desloratadine/pseudoephedrine is indicated for the symptomatic treatment of seasonal allergic rhinitis when accompanied by nasal congestion.
Further reading
- Anolik R . Desloratadine and pseudoephedrine combination therapy as a comprehensive treatment for allergic rhinitis and nasal congestion . Expert Opin Drug Metab Toxicol . 5 . 6 . 683–94 . June 2009 . 19473112 . 10.1517/17425250902980187 . 22633518 .
Notes and References
- Web site: Clarinex-D 12 Hour- desloratadine and pseudoephedrine sulfate tablet, extended release . DailyMed . 15 March 2019 . 1 March 2020 . 16 February 2020 . https://web.archive.org/web/20200216122548/https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=61a1562b-46c6-40ed-af02-305342e76e2f . live .
- Web site: Drug Approval Package: Clarinex-D 24 Hour (Desloratadine/Pseudoephedrine Sulfate) NDA #021605 . U.S. Food and Drug Administration (FDA) . 9 May 2007 . 1 March 2020 . 2 March 2020 . https://web.archive.org/web/20200302081609/https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021605s000TOC.cfm . live .
- Web site: Aerinaze EPAR . European Medicines Agency . 3 August 2007 . 1 March 2020 . 2 March 2020 . https://web.archive.org/web/20200302081610/https://www.ema.europa.eu/en/medicines/human/EPAR/aerinaze . live .
